Is Ozempic cheaper than Wegovy for weight loss in the UK?

Free consultation, reviewed the same day by a GPhC-registered Independent Prescriber — a real clinician, not automated software
Prescription included: no separate prescription fee on top of your treatment price
Free next-working-day tracked delivery by DPD, in plain unbranded packaging, once clinically approved
Priority aftercare seven days a week, with clinical re-review before every repeat order — no subscription, no auto-renewal

Ozempic and Wegovy both contain semaglutide, and the price difference between them is a question our prescribers hear regularly. Here is the honest answer: in the UK, Ozempic is licensed for type 2 diabetes, not weight loss, so comparing its cost to Wegovy's for a weight-loss purpose is comparing two different things entirely. Wegovy is the semaglutide product licensed for weight management here, and the full picture of how Wegovy works is worth understanding before price becomes the main conversation. These are prescription-only medicines; a prescriber assesses whether either is clinically appropriate for you, and that clinical step is not optional.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Why the Ozempic-vs-Wegovy price question is more complicated than it looks

You've seen Ozempic mentioned alongside Wegovy and wondered whether one is a cheaper route to the same result

It is an understandable thought. Both medicines contain semaglutide, they come from the same manufacturer (Novo Nordisk), and the names appear side by side constantly in press coverage. But UK licensing separates them clearly. Ozempic is authorised by the MHRA for type 2 diabetes management. Wegovy is the formulation authorised for weight management in adults, at the higher 2.4mg maintenance dose and now up to 7.2mg following the MHRA's approval of a dedicated single-dose pen in April 2026. Prescribing Ozempic for weight loss in someone without diabetes would be an off-label use, and a reputable prescriber working within UK professional standards would not do that when a licensed alternative exists.

So the question of whether Ozempic is cheaper than Wegovy, while reasonable to ask, does not actually offer a route to cheaper licensed weight-loss treatment. If you want a direct answer to whether Ozempic or Wegovy is cheaper, that page sets out the full pricing context, and if you are also curious about how Ozempic and Wegovy compare on cost across doses and providers, that breakdown covers the detail. If you are wondering whether a different injectable altogether might save you money, you can read whether Saxenda works out cheaper than Wegovy once you factor in dosing frequency and the full course of treatment. The NHS guidance on semaglutide explains both licences plainly.

What private Wegovy actually costs, and what those prices usually include or leave out

Private Wegovy pricing in the UK varies by dose and provider. For context: Eli Lilly's September 2025 price increase for Mounjaro pushed market rates across the GLP-1 category upward, and Wegovy private pricing has moved accordingly; typical private rates across providers now sit roughly in the £150–£375 per month range depending on dose and what is bundled in, though the figures reported vary and are worth treating as indicative rather than fixed. That range is the honest market picture.

What headline prices sometimes omit is telling. A low-looking number may not cover the consultation fee, the prescription charge, delivery, or any aftercare if something concerns you between doses. Those costs appear later, or they appear not at all because the clinical oversight was not there to begin with. If you want to understand what shapes Wegovy's price in the UK, that page goes through the components. And if you have come across a Wegovy voucher code somewhere, it is worth reading why discount codes for prescription medicines are a red flag rather than a deal.

A short practical note: if your payday lands on a Monday, or you want to order before a bank holiday, the 12pm cut-off for same-day dispatch matters, plan around it and your pen arrives the next working day rather than sitting in a depot over a long weekend.

Where Ozempic's licensing leaves weight-loss patients, and what IS licensed instead

If you do not have type 2 diabetes, Ozempic is simply not the right medicine for you in the UK, regardless of price. The two weight-loss medicines licensed here are Wegovy (semaglutide at the higher maintenance dose) and Mounjaro (tirzepatide), which activates both GLP-1 and GIP receptors and produced greater average weight reduction than semaglutide 2.4mg in the SURMOUNT-5 head-to-head trial published in the New England Journal of Medicine in 2025. NICE appraised tirzepatide in TA1026 and recommends it for eligible adults. You can explore both licensed treatment options and see how they compare.

Eligibility for either medicine depends on BMI, weight-related health conditions, and your full clinical picture, not on which product has the lower price tag at a given pharmacy. A prescriber at a regulated service will weigh all of that before any recommendation is made. You can see the clinical team that does this at our prescriber profile.

Price is a reasonable question; 'cheapest' is the wrong test for a prescription medicine

Anyone comparing costs across providers is doing something sensible. For those tracking the market, it is also worth keeping an eye on Ozempic and Wegovy price cuts, since shifts in manufacturer pricing affect what private providers charge across the board. Sellers offering semaglutide or tirzepatide without a prescription, or at prices far below market rates, are a category the MHRA has warned about repeatedly, and understanding exactly how much semaglutide is in Ozempic matters when assessing whether cut-price products contain what they claim. Counterfeit pens have been seized in large quantities across the UK; some contained the wrong medicine entirely. You can check any online pharmacy on the GPhC pharmacy register in under a minute, our registration number is 9012878.

At nume, one transparent price covers the consultation, prescription, treatment, and next-working-day delivery. We are not the cheapest option available. That is a deliberate choice, not an oversight. The price reflects genuine clinical oversight, a licensed UK supply chain, and aftercare seven days a week. If you want to know whether you are eligible, the right starting point is a conversation with a prescriber, not a price comparison. Check your eligibility with our clinical team at no cost.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions